• About us
  • Membership
  • Contact us
  • Sat June 25, 2022

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

Soberana-02 COVID-19 vaccine

Total:2

  • Iran-Cuba vaccine enters phase three clinical trials 2021-04-26 16:46

    Iran-Cuba vaccine enters phase three clinical trials

    TEHRAN – Iran started on Monday the third phase of the human trial of the Soberana-02 coronavirus vaccine, jointly developed with Cuba.

  • Cuban coronavirus vaccine to start third clinical trial phase in Iran 2021-04-18 17:49

    Cuban coronavirus vaccine to start third clinical trial phase in Iran

    TEHRAN – The Cuba-Iran Soberana-02 COVID-19 vaccine received a code of ethics to start the third phase of the clinical trial in Iran, according to the Ministry of Health.

All Pages

Latest

  • UN finds “well-aimed” Israeli bullets killed veteran journalist Abu Aqleh 

  • Italian flamingos glamour of birdwatching in southwest Iran, tourism minister says

  • Abadan Sacred Defense museum in need of investment, minister says

  • The valleys of Assassins, a drive back in time

  • Carlo Rovelli’s “Order of Time” published in Persian

  • Turkish publisher buys copyrights to two Persian children’s books     

  • Tehran museum hosts exhibition of minimalism, conceptual art

  • The power is held by Englishmen!

  • UNHCR holds World Refugee Day in Iran for first time since COVID-19

  • Iran pioneer in helping Afghan earthquake victims

  • Plans outlined to mark world narcotics week

  • Iran too strong for Canada in 2022 VNL

  • Iran says nuclear talks to lift sanctions will resume soon

  • Persepolis complete signing of Saeid Sadeghi

  • Export from Tehran province rises 17% in 2 months yr/yr

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio